# CeCurio (MVZ Tübingen oncology)

Source: https://onco.cc/institutions/cecurio/  
OnCo record `cecurio` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

CeCurio, the oncology and haematology practice of MVZ Tübingen, offers personalised peptide vaccines built with the sequencing laboratory CeGaT, with real-world survival data in glioblastoma.

## Summary

The oncology and haematology practice at MVZ Tübingen offers personalised cancer therapy and advanced diagnostics, including personalised peptide vaccines developed in collaboration with CeGaT; Future of Cancer Care Today notes real-world survival data in glioblastoma and lists it as patient-bookable in Germany.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: MVZ Tübingen
- Tags: fcct-directory
- City: Tübingen, DE
- Type: hospital
- Website: https://mvz-tuebingen.de/en/oncology/

## Sources

- Official website: https://mvz-tuebingen.de/en/oncology/
- Listed on Future of Cancer Care Today (Sijbrandij Foundation): https://sijbrandijfoundation.org/fcct

## Connected records

- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/)
- technologies: [Personalised neoantigen (mRNA) vaccines](https://onco.cc/technologies/neoantigen-mrna-vaccine/)

---
JSON: https://onco.cc/api/v1/entities/cecurio.json